Health Care REITs LTC Properties (LTC) and Sabra Health Care REIT (SBRA) were upgraded at JMP, citing multiple tailwinds are ...

Sabra Health Care REIT rated buy, undervalued compared to peers. Investment-grade ratings, +7% dividend yield opportunity.

Fintel reports that on January 7, 2025, JMP Securities upgraded their outlook for Sabra Health Care REIT (NasdaqGS:SBRA) from ...

JMP Securities upgraded Sabra Health Care (SBRA) to Outperform from Market Perform with a $20 price target The firm expects “multiple ...

Jefferies lowered the firm’s price target on Sabra Health Care to $20 from $21 and keeps a Buy rating on the shares as part ...

In a report released today, Aaron Hecht from JMP Securities upgraded Sabra Healthcare REIT (SBRA – Research Report) to a Buy, with a price ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jefferies lowered the firm’s price target on National Health Investors (NHI) to $66 from $77 and keeps a Hold rating on the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...